the subjective side-effects of almost equivalent intravenous iodine doses of the three new low-osmolar contrast media , ioxaglate ( hexabrix ) , iopamidol ( niopam ) and iohexol ( omnipaque ) have been recorded and are found to be generally comparable .
C0022005
iohexol
C0729203
omnipaque